Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag FDA approves Paradromics' brain-computer interface trial to restore speech in severely impaired patients.

flag Paradromics has received FDA approval for a long-term clinical trial of its brain-computer interface, the Connexus, to restore speech in people with severe motor impairments. flag The implant, a dime-sized device with 421 microwire electrodes, records neural activity from the motor cortex to translate imagined speech into text or synthetic voice output using the user’s own voice. flag The trial, starting early next year, will initially involve two participants and assess safety, communication speed, and the ability to control a computer cursor. flag The system has shown high data transmission rates in animal tests, potentially offering faster communication than other BCIs. flag If successful, the trial may expand to up to ten participants with dual implants.

3 Articles

Further Reading